---
title: "Mohini Health & Hygiene Ltd (MHHL) — Share Price, Financials & Analysis"
symbol: "MHHL"
company: "Mohini Health & Hygiene Ltd"
canonical: "https://tapetide.com/stocks/MHHL"
isin: "INE450S01011"
nse_symbol: "MHHL"
sector: "Healthcare"
industry: "Medical Equipment"
market_cap_cr: 58.35
generated_at: "2026-09-13T19:21:58.365Z"
---

# Mohini Health & Hygiene Ltd (MHHL)

Canonical page: https://tapetide.com/stocks/MHHL

## Company

- **NSE Symbol:** MHHL
- **ISIN:** INE450S01011
- **Sector:** Healthcare
- **Industry:** Medical Equipment
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2018-02-16
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** mohinihealthandhygiene.com

## About

Incorporated in 2009, Mohini Health and Hygiene Ltd is engaged in the business of healthcare and hygiene products.[1]

## Latest Price

- **Price:** ₹33.85
- **Change:** +1.35 (+4.15%)
- **Open:** ₹32
- **Day High:** ₹33.95
- **Day Low:** ₹31.7
- **Previous Close:** ₹32.5
- **Volume:** 7500
- **As Of:** 2026-09-11T09:49:24+00:00

## Key Fundamentals

Observed at 2026-09-11T04:50:50.733742Z.

- **Market Cap:** ₹58.35 Cr
- **Classification:** SME
- **P/E (reported):** -3.6
- **Book Value:** ₹48.62
- **Price to Book:** 0.67
- **Dividend Yield:** 1.54%
- **ROE:** 5.56%
- **ROCE:** 10.41%
- **Debt to Equity:** 0.39
- **Revenue (yearly):** ₹144.46 Cr
- **Net Income:** ₹-16.43 Cr
- **EBITDA:** ₹-10.7 Cr
- **52-Week High:** ₹54.5
- **52-Week Low:** ₹29.2
- **RSI (14):** 46.05

## Tapetide Score

- **Score:** 49 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Falling
- **Percentile:** 43.6 (of 4473 scored stocks)
- **Confidence:** 84%
- **Data coverage:** 67%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 28.06 | 9% |
| growth | 20.28 | 9% |
| momentum | 27.43 | 12% |
| ownership | 50 | 24% |
| quality | 48.02 | 22% |
| valuation | 79.34 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.68 times its book value
- Debtor days have improved from 45.5 to 25.6 days.

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 1.34% over past five years.
- Company has a low return on equity of 4.66% over last 3 years.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | 116.3% | 17.25% | 199.11% |
| ebitda margin growth | -157.21% | -169.19% | -159.74% |
| net income growth | -378.47% | -253.55% | -369.34% |
| revenue growth | -19.16% | -9% | 1% |
| roce | -34.28% | -27.46% | 13.42% |
| roe | -47.79% | 7.92% | -29.97% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 72 | 63 | 46 | 82 | 99 | 93 | 101 | 98 | 91 | 76 | 74 | 71 |
| Expenses | 60 | 59 | 40 | 78 | 94 | 85 | 94 | 92 | 82 | 74 | 76 | 71 |
| Operating Profit | 12 | 5 | 6 | 4 | 5 | 7 | 8 | 6 | 9 | 3 | -2 | 0 |
| OPM % | 17 | 7 | 13 | 4.3 | 5 | 8 | 8 | 6 | 10 | 3.4 | -3.2 | 0.2 |
| Other Income | 0 | 0 | 1 | 6 | 6 | 0 | 4 | 4 | 1 | 3 | 3 | -7 |
| Interest | 2 | 2 | 2 | 2 | 1 | 3 | 2 | 2 | 1 | 2 | 2 | 2 |
| Depreciation | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 |
| Profit before tax | 7 | 0 | 2 | 6 | 8 | 3 | 7 | 6 | 7 | 2 | -4 | -11 |
| Tax % | 0 | 3780 | 25 | 31 | 32 | 46 | 28 | 10 | 30 | 35 | -1 | -1 |
| Net Profit | 7 | -2 | 2 | 4 | 5 | 2 | 5 | 6 | 5 | 1 | -4 | -11 |
| EPS in Rs | 4.1 | -1.01 | 0.9 | 2.09 | 2.81 | 0.91 | 2.83 | 3.07 | 2.64 | 0.61 | -2.17 | -6.16 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 137 | 148 | 127 | 128 | 135 | 127 | 192 | 200 | 168 | 144 |
| Expenses | 127 | 130 | 107 | 117 | 118 | 118 | 179 | 186 | 155 | 147 |
| Operating Profit | 10 | 17 | 20 | 11 | 17 | 9 | 13 | 14 | 12 | -2 |
| OPM % | 7 | 12 | 16 | 8 | 12 | 7 | 7 | 7 | 7 | -1.5 |
| Other Income | 3 | 2 | 1 | 6 | 0 | 7 | 6 | 8 | 4 | -5 |
| Interest | 3 | 7 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 4 |
| Depreciation | 3 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 5 |
| Profit before tax | 8 | 7 | 10 | 8 | 8 | 8 | 11 | 13 | 9 | -15 |
| Tax % | 27 | 30 | 26 | 18 | 25 | 29 | 36 | 20 | 31 | -1 |
| Net Profit | 6 | 5 | 8 | 6 | 6 | 5 | 7 | 11 | 6 | -15 |
| EPS in Rs | 18.83 | 2.81 | 4.21 | 3.46 | 3.09 | 2.99 | 3.72 | 5.89 | 3.25 | -8.32 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 15 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 21 | 40 | 48 | 54 | 59 | 65 | 71 | 82 | 87 | 72 |
| Borrowings | 65 | 56 | 51 | 42 | 43 | 44 | 28 | 23 | 35 | 35 |
| Other Liabilities | 18 | 20 | 16 | 19 | 22 | 22 | 21 | 17 | 28 | 28 |
| Total Liabilities | 107 | 133 | 133 | 133 | 143 | 148 | 138 | 140 | 168 | 153 |
| Fixed Assets | 41 | 64 | 63 | 60 | 64 | 50 | 49 | 40 | 37 | 35 |
| CWIP | 21 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 4 |
| Other Assets | 44 | 70 | 70 | 72 | 79 | 98 | 89 | 98 | 127 | 113 |
| Total Assets | 107 | 133 | 133 | 133 | 143 | 148 | 138 | 140 | 168 | 153 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 13 | 2 | 14 | 16 | 11 | -7 | 26 | 15 | 30 | 10 |
| Cash from Investing Activity | -19 | -5 | -4 | -2 | -9 | 10 | -6 | -1 | -29 | -16 |
| Cash from Financing Activity | 6 | 5 | -11 | -14 | -3 | -3 | -20 | -10 | 8 | -2 |
| Net Cash Flow | 0 | 2 | -2 | 1 | -1 | 0 | 0 | 4 | 9 | -9 |
| Free Cash Flow | -6 | -3 | 10 | 14 | 2 | 3 | 23 | 14 | 8 | 2 |
| CFO/OP | 128 | 13 | 76 | 152 | 67 | -63 | 219 | 126 | 267 | -427 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 64 | 89 | 82 | 65 | 60 | 112 | 67 | 72 | 39 | 26 |
| Inventory Days | 37 | 44 | 79 | 94 | 126 | 106 | 65 | 55 | 117 | 134 |
| Days Payable | 13 | 15 | 16 | 28 | 25 | 18 | 16 | 10 | 29 | 19 |
| Cash Conversion Cycle | 88 | 117 | 145 | 131 | 161 | 200 | 116 | 117 | 127 | 141 |
| Working Capital Days | 1 | 47 | 66 | 70 | 66 | 110 | 96 | 116 | 120 | 130 |
| ROCE % | 13 | 14 | 14 | 10 | 10 | 9 | 12 | 14 | 14 | -3 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 62.33% | 62.33% | 62.33% | 62.33% | 63.28% | 63.28% | 63.28% | 64.02% | 64.02% | 64.02% | 64.02% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 29.38% | 27.79% | 27.13% | 26.93% | 27.39% | 27.54% | 27.89% | 27.7% | 24.39% | 24.54% | 26.75% |
| Others | 8.29% | 9.88% | 10.54% | 10.74% | 9.32% | 9.18% | 8.82% | 8.28% | 11.59% | 11.44% | 9.23% |
| No. of Shareholders | 371 | 575 | 616 | 616 | 597 | 593 | 733 | 749 | 737 | 667 | 639 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 5 / 7 / 7

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 31.77 | Buy |
| EMA (10) | 32.5 | Buy |
| SMA (20) | 33.64 | Buy |
| EMA (20) | 33.12 | Buy |
| SMA (50) | 34.26 | Sell |
| EMA (50) | 34.56 | Sell |
| SMA (100) | 36.61 | Sell |
| EMA (100) | 36.54 | Sell |
| SMA (200) | 40.19 | Sell |
| EMA (200) | 40.6 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 51.39 | Neutral |
| MACD (12,26,9) | -0.82 | Buy |
| Stochastic (14,3,3) | 37.22 | Neutral |
| ADX (14) | 21.55 | Neutral |
| Williams %R (14) | -42 | Neutral |
| ATR (14) | 1.39 | High Volatility |
| ROC (12) | -7.51 | Sell |
| Stoch RSI (14) | 76.29 | Neutral |
| UO (7,14,28) | 64.29 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Sep - 17th AGM on 30 September 2026; book closure 24-30 September, remote e-voting from 26 September. | [Copy of Newspaper Publication 9 Sep - 17th AGM on 30 September 2026; book closure 24-30 September, remote e-voting from 26 September.](https://nsearchives.nseindia.com/corporate/MHHL_09092026123855_Newspaper_Advertisement_09-09-2026_MHHLAGM.pdf) |
| 9 July 2026 - Rs. 142.90 crore resolution plan payment completed for Winsome Yarns via SPV. | [Updates 9 July 2026 - Rs. 142.90 crore resolution plan payment completed for Winsome Yarns via SPV.](https://nsearchives.nseindia.com/corporate/MHHL_09072026204445_Intimation_Implementation_Plan_09072026.pdf) |
| 9 April 2026 - Mohini Health & Hygiene confirms corporate governance provisions are not applicable, except Regulation 23 from April 1, 2025. | [Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter 9 April 2026 - Mohini Health & Hygiene confirms corporate governance provisions are not applicable, except Regulation 23 from April 1, 2025.](https://nsearchives.nseindia.com/corporate/MHHL_09042026140309_Non_Applicability_CG_MHHL_09042026.pdf) |
| 9 April 2026 - Bansal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | [Disclosure under SEBI Takeover Regulations 9 April 2026 - Bansal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.](https://nsearchives.nseindia.com/corporate/team_sandeshc_09042026132828_34.pdf) |
| 8 Sep - 17th AGM on 30 Sep 2026; record date 23 Sep and book closure 24-30 Sep 2026. | [Record Date 8 Sep - 17th AGM on 30 Sep 2026; record date 23 Sep and book closure 24-30 Sep 2026.](https://nsearchives.nseindia.com/corporate/MHHL_08092026225057_Intimation_recorddate_bookclosure_signed.pdf) |
| 8 Sep - 17th AGM on 30 Sep 2026; annual report issued, with migration and related-party resolutions. | [Shareholders meeting 8 Sep - 17th AGM on 30 Sep 2026; annual report issued, with migration and related-party resolutions.](https://nsearchives.nseindia.com/corporate/MHHL_08092026223452_Intimation_of_Notice_of_AGMAnnual_ReportBook_Closure.pdf) |
| 8 May 2026 - MHHL approved implementation of NCLT plan for Winsome Yarns acquisition via SPV; total plan ₹162.9 crore. | [Outcome of Board Meeting 8 May 2026 - MHHL approved implementation of NCLT plan for Winsome Yarns acquisition via SPV; total plan ₹162.9 crore.](https://nsearchives.nseindia.com/corporate/MHHL_08052026164320_Revised_Outcome_01052026_MHHL.pdf) |
| 8 April 2026 - Regulation 74(5) certificate issued for quarter ended March 31, 2026. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 8 April 2026 - Regulation 74(5) certificate issued for quarter ended March 31, 2026.](https://nsearchives.nseindia.com/corporate/MHHL_08042026110931_Certificate_74_5_DepositoryandParticipantReg_2018.pdf) |
| 7 March 2026 - Board approved director evaluations, omnibus related-party transactions for FY2026-27, trust deed draft, and policy review. | [Outcome of Board Meeting 7 March 2026 - Board approved director evaluations, omnibus related-party transactions for FY2026-27, trust deed draft, and policy review.](https://nsearchives.nseindia.com/corporate/MHHL_07032026160746_Outcome_BM_07032026_SIGNED.pdf) |
| 6 January 2026 - Certificate under Reg 74(5) confirming dematerialisation details for quarter ended Dec 31, 2025. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 6 January 2026 - Certificate under Reg 74(5) confirming dematerialisation details for quarter ended Dec 31, 2025.](https://nsearchives.nseindia.com/corporate/MHHL_06012026165630_Compliance_Certificate_74_DP.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_31987_MHHL_2025_2026_A_4713896_08092026225735.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28945_MHHL_2024_2025_A_3323473_08092025190753.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25812_MHHL_2023_2024_05092024155513.pdf) |
| from nse | [Annual Report 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_23747_MHHL_2022_2023_07092023160556_09072023170021.zip) |
| from nse | [Annual Report 2022 from nse](https://archives.nseindia.com/annual_reports/SME_AR_21703_MHHL_2021_2022_08092022154544.zip) |
| from nse | [Annual Report 2021 from nse](https://archives.nseindia.com/annual_reports/SME_AR_19718_MHHL_2020_2021_08092021165001_09082021170013.zip) |
| from nse | [Annual Report 2020 from nse](https://archives.nseindia.com/annual_reports/SME_AR_17573_MHHL_2019_2020_07092020205037_07092020210014.zip) |
| from nse | [Annual Report 2019 from nse](https://archives.nseindia.com/annual_reports/SME_AR_15882_MHHL_2018_2019_06092019180507_06092019190007.zip) |
| from nse | [Annual Report 2018 from nse](https://archives.nseindia.com/annual_reports/SME_AR_13720_MHHL_2017_2018_28092018153549.zip) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:21:58.365Z.